Paper Details
- Home
- Paper Details
Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.
Author: IoannidisJohn P A, MauriDavide, PavlidisNicholas
Original Abstract of the Article :
Interest in the use of preoperative systemic treatment in the management of breast cancer has increased because such neoadjuvant therapy appears to reduce the extent of local surgery required. We compared the clinical end points of patients with breast cancer treated preoperatively with systemic the...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1093/jnci/dji021
データ提供:米国国立医学図書館(NLM)
Neoadjuvant vs. Adjuvant Therapy in Breast Cancer: A Tale of Two Treatments
The world of breast cancer treatment is a complex and ever-evolving landscape. This meta-analysis delves into the effectiveness of systemic treatment delivered before surgery (neoadjuvant therapy) compared to treatment delivered after surgery (adjuvant therapy). The analysis, based on a comprehensive review of randomized trials, aimed to determine which approach yielded better clinical outcomes for breast cancer patients. The results suggest that there is no clear advantage to either approach, with both neoadjuvant and adjuvant therapy demonstrating similar efficacy. This finding highlights the need for personalized treatment plans based on individual patient characteristics and tumor biology.
Two Paths in the Desert of Breast Cancer Treatment
This meta-analysis explores the effectiveness of two common approaches to systemic treatment in breast cancer: neoadjuvant therapy, where treatment is delivered before surgery, and adjuvant therapy, where treatment is delivered after surgery. The findings suggest that both approaches are equally effective, offering patients a choice in their treatment plan based on individual needs and preferences. This is a valuable insight that empowers patients to actively participate in their treatment decisions.
Navigating the Breast Cancer Landscape
This research underscores the importance of personalized treatment plans in breast cancer management. The findings suggest that both neoadjuvant and adjuvant therapy are effective treatment options, but the best approach for an individual patient depends on various factors, including tumor characteristics and personal preferences. It is crucial to consult with a healthcare professional to discuss all treatment options and make informed decisions based on your individual needs and circumstances.
Dr.Camel's Conclusion
This study highlights the complexity of breast cancer treatment, with no single approach being universally superior. The findings suggest that both neoadjuvant and adjuvant therapy can be effective, emphasizing the importance of personalized treatment plans based on individual patient characteristics and tumor biology.
Date :
- Date Completed 2005-02-15
- Date Revised 2023-07-18
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.